These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8707957)

  • 1. The pathology of cornea in Tangier disease (familial high density lipoprotein deficiency).
    Winder AF; Alexander R; Garner A; Johnston D; Vallance D; McCreanor G; Frohlich J
    J Clin Pathol; 1996 May; 49(5):407-10. PubMed ID: 8707957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular manifestations of familial high-density lipoprotein deficiency (Tangier disease).
    Chu FC; Kuwabara T; Cogan DG; Schaefer EJ; Brewer HB
    Arch Ophthalmol; 1979 Oct; 97(10):1926-8. PubMed ID: 226043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confocal microscopy and corneal sensitivity in a patient with corneal manifestations of Tangier disease.
    Herrmann WA; von Mohrenfels CW; Lohmann CP
    Cornea; 2004 Nov; 23(8):825-7. PubMed ID: 15502486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The storage lipids in Tangier disease. A physical chemical study.
    Katz SS; Small DM; Brook JG; Lees RS
    J Clin Invest; 1977 Jun; 59(6):1045-54. PubMed ID: 193870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular complications of Tangier disease.
    Pressly TA; Scott WJ; Ide CH; Winkler A; Reams GP
    Am J Med; 1987 Nov; 83(5):991-4. PubMed ID: 3314502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lecithin cholesterol acyl transferase deficiency. Light and electron microscopic finding from two corneas.
    Bethell W; McCulloch C; Ghosh M
    Can J Ophthalmol; 1975 Oct; 10(4):494-501. PubMed ID: 811335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.
    Francis GA; Knopp RH; Oram JF
    J Clin Invest; 1995 Jul; 96(1):78-87. PubMed ID: 7615839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of high density lipoprotein with adipocytes in a new patient with Tangier disease.
    Frohlich J; Fong B; Julien P; Despres JP; Angel A; Hayden M; McLeod R; Chow C; Davison RH; Pritchard H
    Clin Invest Med; 1987 Sep; 10(5):377-82. PubMed ID: 3677505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual presentation of Tangier disease with gallbladder involvement.
    Bektas M; Savas B; Cetinkaya H; Ensari A; Oztas E; Can B; Ozden A
    Acta Gastroenterol Belg; 2008; 71(4):397-400. PubMed ID: 19317282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneal opacity in LCAT disease.
    Cogan DG; Kruth HS; Datilis MB; Martin N
    Cornea; 1992 Nov; 11(6):595-9. PubMed ID: 1468226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 'Fish-eye disease' familial condition with massive corneal opacities and hypoalphalipoproteinaemia: clinical, biochemical and genetic features.
    Clerc M; Dumon MF; Sess D; Freneix-Clerc M; Mackness M; Conri C
    Eur J Clin Invest; 1991 Dec; 21(6):616-24. PubMed ID: 1778223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tangier disease: epidemiology, pathophysiology, and management.
    Puntoni M; Sbrana F; Bigazzi F; Sampietro T
    Am J Cardiovasc Drugs; 2012 Oct; 12(5):303-11. PubMed ID: 22913675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal opacifications in a low high density lipoprotein syndrome: suspicion of fish eye disease: a case report.
    De Smedt M; Van Ginderdeuren R; De Vos R; Mertens A; Muls E; Foets B
    Bull Soc Belge Ophtalmol; 2001; (282):25-30. PubMed ID: 12455137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fish-eye disease. A new familial condition with massive corneal opacities and dyslipoproteinaemia.
    Carlson LA; Philipson B
    Lancet; 1979 Nov; 2(8149):922-4. PubMed ID: 91022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ocular manifestation in LCAT deficiency--a clinicopathological correlation].
    Viestenz A; Seitz B
    Klin Monbl Augenheilkd; 2003 Jul; 220(7):499-502. PubMed ID: 12886512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal opacification and familial disorders affecting plasma high-density lipoprotein.
    Winder AF; Borysiewicz LK
    Birth Defects Orig Artic Ser; 1982; 18(6):433-40. PubMed ID: 7171769
    [No Abstract]   [Full Text] [Related]  

  • 17. Massive omental reticuloendothelial cell lipid uptake in Tangier disease after splenectomy.
    Schaefer EJ; Triche TJ; Zech LA; Stein LA; Kemeny MM; Brennan MF; Brewer HB
    Am J Med; 1983 Sep; 75(3):521-6. PubMed ID: 6614036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of experimental lipid keratopathy: corneal and plasma lipids.
    Reddy C; Stock EL; Mendelsohn AD; Nguyen HS; Roth SI; Ghosh S
    Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1492-6. PubMed ID: 3623835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tangier disease: one explanation of lipid storage.
    Herbert PN; Forte T; Heinen RJ; Fredrickson DS
    N Engl J Med; 1978 Sep; 299(10):519-21. PubMed ID: 210378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Familial alpha lipoprotein deficiency. Tangier disease, familial hypoalphalipoproteinemia and familial deficiency of lecithin cholesterol acyltransferase deficiency].
    Dioguardi N; Vergani C
    Minerva Med; 1983 Mar; 74(12):585-94. PubMed ID: 6835549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.